ID   NCC-PS1-C1
AC   CVCL_C5Z2
DR   Wikidata; Q116049882
RX   PubMed=36103079;
WW   https://en.cellline.jp/product/ncc-ps1-c1/
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: 39 hours (PubMed=36103079).
CC   Sequence variation: Mutation; HGNC; 1787; CDKN2A; Simple; p.Cys72Ter (c.216C>A); Zygosity=Unspecified (PubMed=36103079).
CC   Sequence variation: Mutation; HGNC; 7883; NOTCH3; Simple; p.Arg1873Cys (c.5617C>T); ClinVar=VCV000932356; Zygosity=Unspecified (PubMed=36103079).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=36103079).
CC   Omics: SNP array analysis.
CC   Misspelling: NCC-PS-C1; Note=In Cellosaurus releases 44 to 47.
CC   Derived from site: In situ; Popliteal fossa, hypodermis; UBERON=UBERON_0013069+UBERON_0002072.
ST   Source(s): PubMed=36103079
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13
ST   D16S539: 12
ST   D21S11: 31
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18,19
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 4
//
RX   PubMed=36103079; DOI=10.1007/s13577-022-00787-1;
RA   Akiyama T., Yoshimatsu Y., Noguchi R., Sin Y., Tsuchiya R., Ono T.,
RA   Sugaya J., Kobayashi E., Yoshida A., Ohtori S., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-PS1-C1: a novel cell line
RT   of pleomorphic sarcoma from a patient after neoadjuvant
RT   radiotherapy.";
RL   Hum. Cell 35:2011-2019(2022).
//